Home > Insider Trading > Filing (0001493152-21-015788)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
876343	Lineage Cell Therapeutics Inc.	LCTX	Biological Products, (No Disgnostic Substances) (2836)	943127919

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1325697	J Deborah Andrews	C/O Lineage Cell Therapeutics 2173 Salk Avenue, Suite 200 Carlsbad CA 92008		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares, No Par Value	Acquisiton	2021-06-29	24,720	$2.20	34,720	No	4	M	Direct
Common Shares, No Par Value	Disposition	2021-06-29	19,142	$2.93	15,578	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Shares	Stock Option (right to buy)	Disposition	2021-06-29	24,720	$0.00	24,720	$2.20

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2021-06-30	No	4	M	Direct

Footnotes

The price reported is a weighted average. These shares were sold in multiple transactions at a price of $2.93 or $2.935. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
This option became exercisable in four equal quarterly installments after the date of grant on July 1, 2016